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Abstract 
Abstract 
Typhoid fever is one of the lJll!ior health problems in Bangladesh. It is caused by the 
bacteriwn SaJroone/la enlerica serover Typhi (S. Typhi). The infection rate of S. Typhi is 
higher in children. The conventional diagnostic methods of typhoid have limitations. 
Most commonly used Widal test gives a high rate of false positive results. As such 
PCR method was tried to diagnose typhoid fever in some selected patients of 
Bangladesh. Fifty three (53) patients were enroUed in this study from Dhaka hospital 
of ICDDR, B and Kamalapur field site. Among them 27 (5 I %) persons are male. 
Blood was coUected from all patients. Three different methods namely, a method by 
Haque et ai , direct boiling method and commercial Qiagen kit method were tried to 
extract Salmonella Typhi DNA from blood and invitro samples. To optimize the DNA 
extraction from blood invitro grown S. Typhi bacteria was spiked into blood. From 
the three different methods, commercial Qiagen kit method did well comparably to 
extract DNA from spiked blood than the other methods. However, none of these 
methods did appear promising to extract DNA from patient's blood. Because low 
percentage of PCR positive were found from patient' s blood culture positive samples. 
So another method was tried which was described earlier by Boom' s et aI. [1990] for 
detection of S. Typhi from blood of suspected typhoid fever patient. This method 
(Boom's et aI.[1990]) showed comparably satisfactory results than the other methods 
to deal with patient' s blood. In this method the percentage of PCR positive was 35.7 
% among the blood culture confinned patients. DNA extraction was also done in 
blood culture negative samples by this method. Here 30.8% positive for PCR was 
found among the culture negative samples. However there are some drawbacks in 
DNA extraction procedures especially in low concentrated samples. In the method by 
Haque et aI. [200 I] unexpected band was found and same phenomenon was observed 
in direct boiling method. This might be due to contamination with S. Typhi. It seems 
that, S. Typhi can be detected from patient' s blood specimen by PCR method for 
diagnostic purpose. Howeve~ more study is needed to evaluate the efficacy of PCR 
method with some modifications for detecting S. Typhi at low concentration in blood. 
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Introduction 
Introduction 
1.1 Background 
Typhoid fever is caused by Salmonella enlerica serovar Typhi (S Typhi) which is an 
important health problem in many developing countries [I]. S Typhi is a highly virulent 
host restricted invasive pathogen that affects only humans [2]. Most of this burden occurs 
among people of low-income regions, particularly in Asia, Africa, Lati~ America, the 
Caribbean, and Oceania. About 80% of cases come from Bangladesh, China, India, 
Indonesia, Laos, Nepal, Pakistan, and Vietnam [3]. It has been estimated that, 16-33 million 
annual cases resulting in 216,000 deaths in endemic areas and its incidence is highest in 
children and young adults between 5 and 19 years old [4]. Although young children are also 
susceptible. In nonendemic areas, disease outbreak may occur from a contaminated food or 
through carriers [9, 10]. 
The disease is characterized by the onset of prolonged high fever, severe headache, malaise 
and abdominal pain [5]. The illness often causes diarrhea, especially in younger children, 
whereas constipation is common in older children and adults. Serious complications occur in 
up to 10% of typhoid fever patients, especially those who have been i II for more than two 
weeks and have not received proper treatment [5]. Almost half of the treated patients 
continue to excrete the pathogen for about one month after the symptoms have been 
disappeared and 5% still continue upto five months [6, 7]. Approximately 3% become 
chronic carriers and continue to excrete the or.ganism lifelong [8] . The encounters of S. 
Typhi to humans are generally caused through fecal-oral route from infected individuals to 
healthy ones [II]. 
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1.2 Structure & Comparisn of the S. Typhi Genome 
The genus Salmonella has 3 specIes, Salmonella enterica, Salmonella bongori and 
Salmonella subterranean [15]. S. enlerica has seven subspecies consistently delineated by 
sequence variation. The majority of diseases causing serovars are from subspecies, 
Typhimurium, Typhi and Paratyphi [12]. 
Complete genome sequence data provides the genetic characterization of pathogens and 
their hosts. The S. Typhi genome consists of 479 kb encoding around 4000 genes where over 
200 genes are functionally inactive. Comparison of S. Typhi isolates from around the world 
indicates that, they are highly related (clonal) and they emerged from a single point of 
origin, around 30,000 - 50,000 years ago. Evidence suggests that S. Typhi undergoing gene 
degradation and it has also recently acquired genes, such as those encoding the Vi antigen 
by horizontal gene transfer [17]. 
Salmonella Typhi CTIS has a large circular chromosome consisting of 4.S Mb and two 
plasm ids are pHCMI and pHCM2, which are 21S kb and 106 kb respectively. S. Typhi 
CT IS has 4646 genes and 204 pseudogenes, nine of which resemble intact genes in strain 
Ty2. Along with the 195 pseudogenes common with CTIS, strain Ty2 has also II unique 
ones. S. Typhi Ty2 consists one large chromosome that is 4.7 Mb with an average G+C 
content of 52.05% [16]. 
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Fig 2: Circular genome map of S. Typhi [IS] 
The Ty2 genome has 4,545 ORFs and pseudogenes, where 4,516 are shared with CT IS 
(outer circle, blue) and 29 of which are unique (pink). The second circle shows the locations 
and orientations of rRNA operons (red) and tRNAs (turquoise). The third circle shows 
insertion element distributions. The fourth circle shows the scale in base pairs. The fifth 
circle shows the GIC skew, calculated for each sliding window of 10 kb along the genome. 
The sixth and seventh (innermost) circles show the CTIS and Ty2 genome comparison 
where, blue indicates collinear regions, red indicates inverted regions, green indicates a 
region that is translocated and inverted again within the half-genome inversion region, and 
yellow indicates unique regions [IS]. More discrepancies are found when looking at 
prophages. Four prophages are located in identical parts of the genome relative to the 
adjacent non phage genes, and both strains contain parts of prophages that are unique to one 
another (16). 
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1.3 Antigenic types of Salmonella Typbi 
Salmonella is a genus of rod-shaped, Gram-negative, non-spore forming, predominantly 
motile bacteria belonging to the family of Enterobacteriaceae [12], with more than 2S0 I 
serotypes [13]. Its diameter is around 0.7 to I.S 11m and lengths from 2 to Slim. The bacteria 
contains nagella which projected along with all directions [12]. 
Figure I: Structure of Salmonella Typhi [67]. 
As with all Enterobacteriaceae, the genus Salmonella has three kinds of m:yor antigens with 
identifying characteristics [14]-
a) Somatic or 0 antigens (bacterial endotoxins): These are heat stable and alcohol resistant. 
Cross-absorption studies individualize a large number of antigenic factors, 67 of which are 
used for serological identification. 
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b) H antigen: This is a protein structure associated with the flagella. Flagellar antigens are 
heat-labile proteins. By mixing colonies of Salmonella with flagella-specific antisera gives 
a characteristic pattern of agglutination. 
c) Surface Vi (for virulence) antigen: This is a polysaccharide on the exterior of the cell 
wall. The surface antigens (Vi) in Salmonella may mask 0 antigens, and the bacteria will 
not be agglutinated with '0 ' antigen specific antisera [14]. 
1.4 Etiology 
Most current understanding of S. Typhi is from observing the disease in humans, volunteer 
research and animal models. S. Typhimurium in the murine model is the best characterization 
of typhoid fever in humans [20]. In murine model during first exposure, the S. Typhi is 
ingested and it enters into the small intestine through the microfold cells (M cells) of the 
Peyer's patches. After being endocytosed by M cells, the bacterium is able to migrate to the 
mesenteric lymph nodes and then multiply [20]. A fterwards the bacteria are released into 
blood stream and circulate to cause a systemic infection [21]. S. Typhi is then taken up from 
the blood by antigen presenting cells such as the macrophages that line over the liver, 
spleen, and bone marrow sinusoids. The bacteria is able to replicate and stay in the 
macrophages [22]. The macrophages can lose the ability to kill intracellular bacteria. The 
clinical symptoms like fever, nausea, constipation and diarrhoea are observed when the 
bacteria reenters into the circulation. S. Typhi is then removed from the blood via the gall 
bladder to the small intestine. 
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are not sufficiently sensitive and specific [50]. Widal test has a presumptive diagnostic value 
in non endemic areas but in endemic areas it ' s use is controversial [51]. 
1.7.1 Widal test 
The Widal test is used to demonstrate rising titres of antibodies to flagellar (H) and somatic 
(0) antigens in typhoid and paratyphoid fever [52, 53]. An increased 0 antibody level 
signifies acute infection, whilst an increased H antibody level may indicate the serotype of 
the infecting organism. Widal test has limited use, because H and 0 antibody levels may rise 
non-speci fically due to cross reactions with other enterobacteriaceae. 
1.8 Diagnosis of typhoid by nested Polymerase Chain Reaction (PCR) 
The diagnosis of typhoid fever can be possible by Polymerase Chain Reaction (PCR) using 
blood and stool as sole source of template DNA of Salmonella Typhi [54]. The flagellin 
gene of S. Typhi can be detected by the Polymerase chain reaction (PCR). Nested 
polymerase chain reaction is a modification of polymerase chain reaction intended to reduce 
the contamination in products due to non specific primer binding. In conventional PCR a 
commonly occurring problem is primers binding to incorrect regions of the DNA, giving 
unexpected products (non specific bands). Nested polymerase chain reaction involves two 
sets of primers, used in two successive runs of polymerase chain reaction, the second set 
intended to amplify a secondary target within the first run product [55]. 
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U wanted primer annealing 
No second run primer 
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Figure 4: A schematic diagram of nested peR [55]. 
Step One: The DNA target template is bound by the first set of primers shown in blue. The 
primers may bind to other, similar binding sites which give mUltiple products. However only 
one of these peR products give the intended sequence (multiple products not shown). 
Step Two: peR products from the first reaction are subjected to a second peR run with a 
second new set of primers shown in red [55]. 
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1.9 Treatment of typboid fever 
1.9.1 General management 
Supportive measures are important in the management of typhoid fever, such as oral or 
intravenous hydration, the use of antipyretics, appropriate nutrition and blood transfusions if 
indicated. More than 90"10 of patients can be managed at home with oral antibiotics, reliable 
care and close medical follow-up [57]. However, patients with persistent vomiting, severe 
diarrhea and abdominal distension may require hospitalization and parenteral antibiotic 
therapy. 
1.9.2 Antimicrobial therapy 
In areas of endemic disease typhoid fever is managed at home with antibiotics and bed rest. 
Effective antibiotic treatment for typhoid was developed in 1948, but even with modem 
drugs typhoid still takes the life of about one in every hundred people [58]. Typhoid fever in 
most cases is not fatal. Antibiotics, such as ampicillin, chloramphenicol, trimethoprim-
sulfamethoxazole, amoxicillin and ciprofloxacin, have been commonly used to treat typhoid 
fever in developed countries. Prompt treatment of the disease with antibiotics reduces the 
case-fatality rate to approximately I %. When untreated, typhoid fever persists for three 
weeks to a month. Death occurs in between 10% and 30% of untreated cases [59]. Since the 
appearance of multidrug resistant strain, sensitivity test is very important for selecting drug. 
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1.9.3 Resistance 
Resistance to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole and streptomycin 
are now common, and these agents have not been used as first line treatment since almost 20 
years. Typhoid that is resistant to these agents is known as multidrug-resistant typhoid 
(MDR typhoid). Ciprofloxacin resistance is an increasing problem especially in the Indian 
subcontinent and Southeast Asia. For these patients, the recommended fll"St line of treatment 
is ceftriaxone. It has also been suggested that azithromycin is better at treating typhoid in 
resistant populations than both fluoroquinolone and ceftriaxone drugs [60]. 
1.10 Prevention of typhoid fever 
Sanitation and hygiene are the measures that can be taken to prevent typhoid. Careful food 
preparation and washing of hands are therefore crucial for preventing typhoid. Health 
education is of paramount importance to raise public awareness and induce behaviour 
change [59). 
There are two vaccines currently recommended by the World Health Organization for the 
prevention of typhoid, these are the live, oral Ty21 a vaccine and the injectable Typhoid 
polysaccharide vaccine. Both are between 50% to 80% protective and are recommended for 
travelers to areas where typhoid is endemic [61]. 
1.1 0.1 Vaccination 
Two types of typhoid vaccines are currently by WHO to preventing typhoid fever, (I) An 
oral live-attenuated vaccine, (2) A Vi polysaccharide vaccine for parenteral use. 
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1.10.2 An oral live-attenuated vaccine 
The oral vaccine containing live attenuated Salmonella Typhi Ty21 a strains in enteric coated 
capsules, taken every two days, a total of 3 doses. The capsule must be refrigerated but not 
frozen to achieve maximum efficacy. The vaccination should be completed within a week 
and the booster dose should be given every 5 years. The vaccine recipient should not be 
younger than 6 years [62]. The commercial vaccine is VivotifBema. 
1.10.3 Vi polysaccharide vaccine 
The vaccine is composed of purified Vi ("virulence") capsular polysaccharide antigen of 
Salmonella Typhi isolated from blood cultures. This capsular polysaccharide of S. Typhi is 
conjugated with nontoxic recombinant Pseudomonas aeruginosa exotoxin A and enhances 
immunity. It is given by the parenteral route once a time. This vaccine must be kept at 4°C 
temperature. Children below two years of age are not given this vaccine. A booster dose is 
given every 2 years to maintain protection [63, 64]. The commercial vaccine is Typherix. 
Aim ofthe study 
To optimize the DNA isolation of Salmonella Typhi from blood of patients with enteric 
fever which leads to rapid, sensitive and specific detection of Salmonella Typhi as well as 
typhoid fever using nested PCR procedure. 
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Chapter Two 
Materials and Methods 
Materials and Metbods 
The study was carried out at the Immunology Laboratory of the Laboratory Sciences Division 
of the International Centre for Diarrheal Disease Research, Bangladesh (ICDDR, B). 
2.1 Study Subjects 
Patients with high fever (? 39°C) for 3-7 days with or without diarrhea who came to the 
ICDDR, B hospital or from the Kamalapur field site in Dhaka were enrolled for this study. 
Written consent was taken before taking blood from them. 
2.2 Sample coUection 
One ml blood sample was collected from each suspected typhoid fever patient for DNA 
isolation and 3 ml blood was collected from fi ve healthy adults in EDT A containing tube for 
spiking experiments. 
Fig 5: Collection of blood in EDTA tube 
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2.3 DNA extraction from invitro grown Salmonella Typhi pure culture: 
Salmonella el1lerica serovar Typhi, ST -004 (stored at -70"c) was streaked on MacConkey 
agar plate and incubated over night at 37°C. 
A loop of S. Typhi bacteria from the MacConkey agar plate was taken and suspended into an 
eppendorf tube containing 100 fil of Phosphate Buffered Saline (PBS, 10 IllJ'v1. pH 7.4). The 
suspension was boiled at 100°C in water bath for 10 minutes . The tube was then transferred 
on ice and kept for I minute. After that the suspension was centrifuged at 16099.2 x g for 10 
minutes. The supematant was collected and used as template and positive control for PCR 
(positive control). 
2.4 Prel>aration of S. Typhi bacteria for spiking in blood: 
I . S. Typhi control strain (laboratory strain st-004) was streaked on Luria agar plate (LA) 
and incubated ovemight :!t 37°C. 
2. From the overnight grown plate 2 colonies were inoculated into eppendorf tube 
containing I ml PBS. This was then vortexed for 15 seconds. 
Fig 6: S. Typhi colonies cultu red on Luria Ag!!f med!C!!!! 
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3. Bacterial suspension was then serially diluted down thirty times by 10 fold dilution 
each time. 
4. A IOOIlI of bacterial suspension from each dilution was spread on LA plate for 
determining bacterial count. 
5. Plates were incubated overnight at 3TC and colonjes were counted. 
6. Rest of the bacterial suspensions from each dilution were centrifuged for 8 minutes at 
16099.2 x g and the supernatent was discarded. 
7. A IOOIlI of blood (from healthy subjects) was added on the bacterial pellet into each 
eppendorftube and mixed by pulse vortexing for 5 seconds. 
2.5.1 DNA Extraction procedure from spiked blood by Haque et al. [66]:-
I. S. Typhi spiked blood samples containing serially diluted bacteria were taken into 
eppendorftubes serially. 
2. The tubes were centrifuged for 5 minutes at 11180 x g. 
3. The pellet was mixed with lysis buffer (I ml in each tube) and centrifuged for 6 
minutes at 11180 x g . The supernatent was discarded. 
4. Steps 2 & 3 were repeated. 
5. The pellet was mixed with water (I ml in each tube), and centrifuged for I minute at 
11180 x g. The supernatent was discarded. 
6. Deionized water was added (30 III in each tube) to the pellet and boiled for 20 
minutes. 
7. The samples were kept at 4·C before use. 
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2.5.2 DNA Extraction from spiked blood by direct Boiling:- (Here 100 111 
deionized water was added into the serially diluted bacteria not blood) 
I. S. Typhi spiked blood samples containing serially diluted bacteria were taken into 
eppendorftubes serially. 
2. The tubes were boiled at 100' C in water bath for 10 minutes and then transferred on 
ice and kept for a minute. 
3. The tubes were then centrifuged at 16099.2 x g for 10 minutes. 
4. The supernatant was collected as the source of DNA. 
2.5.3 DNA Extraction from spiked blood by using commercial Qiagen Kit :-
I. S. Typhi spiked blood samples containing serially diluted bacteria were taken into 
eppendorf tubes serially. 
2. Then 20 111 of Proteinase k and 100111 of PBS were added into each of the tubes. 
3. 200 j!I AL buffer was added there and vortexed properly. 
4. The tubes were heated at 56' C for 10 minutes in water bath. 
5. 200 111 ethanol was added into each tube and then vortexed. 
6. The samples were transferred into DNeasy Mini spin column in a 2 ml collection tube. 
7. The columns were centrifuged at 7155.2 x g for I minute and the tubes were placed in 
a new 2 ml collection. 
8. 500 111 of AWl buffer was added into each tube, centrifuged at 7155.2 x g for 
minute, and the flows through with the collection tube were discarded. 
9. The columns were placed in a new collection tube and 500 111 of A W2 buffer was 
added into each column. 
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10. The columns were centrifuged for 3 minutes at 21912.8 x g to dry the DNeasy 
membrane and the flow through was discarded. 
11. The columns were transferred to new eppendorf tubes and 50 /11 of AE buffer were 
added into each column. 
12. Then the tubes were incubated for 5 minutes at room temperature and centrifuged for 
1 minute at I 1180 x g . 
13. Finally the flow through fluids were collected as extracted DNA. 
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2.6.1 DNA extraction from patient's blood specimens by using commercial 
Qiagen Kit :-
I. Blood sample was collected (100 fll) from patients in each labeled eppendorf tube. 
2. Proteinase k (20 fll) and PBS (100 fll) were added into each of the tubes. 
3. AL buffer (200 fll) was added and vortexed properly. 
4. The tubes were heated at 56°C for 10 minutes in water bath. 
5. Ethanol was added (200 fIl) into each tube and then vortexed. 
6. The samples were transferred into DNeasy Mini spin column in a 2 ml collection 
tube (provided by the reagent company). 
7. The columns were centrifuged at 7155.2 x g for I minute and the tubes were 
placed in a new 2 ml collection tube (provided in the kit). 
8. AWl buffer was added (500 fIl) into each tube, centrifuged at 7155.2 x g for I 
minute, and the flows through with the collection tube were discarded. 
9. The columns were placed in a new collection tube (provided by the reagent 
company) and A W2 buffer was added (500 fIl) into each column. 
10. The columns were centrifuged for 3 minutes at 21912.8 x g to dry the DNeasy 
membrane and the flow through were discarded. 
II. The columns were transferred to new eppendorf tubes and AE buffer were added 
(50 fll) into each column. 
12. Then the tubes were incubated for 5 minutes at room temperature and centrifuged 
for I minute at 11180 x g . 
13. Finally the flow through were collected as extracted DNA. 
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2.6.2 DNA extraction from blood of suspected typhoid fever patient by using a 
procedure of R. Boom et aI165]. 
I. Fresh blood (l001i1) was collected and mixed with 900 iii L6 lysis buffer and then 
centrifuged for 10 minutes at 16099.2 x g . 
2. After that, 100 Jl.I supernatant was collected and added 25 iii of diatom suspension into 
it. 
3. The samples were vortexed for 5-10 seconds and vigorously shaked at RT (Room 
Temperature) for 15 minutes using Vary-max Thermolyne shaker at full speed. 
4. The samples were then vortexed again for 5 seconds and centrifuged for 15 seconds at 
18894.2 x g. The supernatant was discarded. 
5. The pellets were washed twice with 500 iii L2 extraction buffer, twice with 500 iii of 
70% ethanol and once with 500 iii of acetone. The tubes were centrifuged for 15 
seconds at 18894.2 x g after each wash. The supernatant was collected for disposal. 
6. Acetone was removed from the tubes and the tubes were placed at 56°C in a dry 
heating block/water bath with lids open for 5-1 0 minutes. 
7. 60lil TE buffer was added to the pellet and vortexed for 10 seconds and then the DNA 
eluted by incubation at 56°C in a heating block/water bath for 10 minutes. 
8. The tubes were centrifuged at 18894.2 x g for 2 minutes and the supernatant 
containing the extracted nucleic acids were collected. 
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2.7 Nested Polymerase Chain Reaction 
2.7.1 Primer sets : 
SI. no Primers: Sequences 
I Primer STI Forward (5 ' -ACT GCT AAA ACC ACT ACT-3') 
2 Primer ST2 Reverse (5 ' -ITA ACG CAG TAA AGA GAG -3 ' ) 
3 Primer sn Forward (5 ' -AGA TGG TAC TGG CGT TGC TC -3 ' ) 
4 Primer ST4 Reverse (5 ' -TGG AGA CIT CGG TCG CGT AG -3') 
Table I : Primer sets 
2.7.2 Master mixture preparation for first round peR 
No Reagent Amount per reaction (conc) Amount per reaction (volume) 
I. PCR buffer 
(with MgCI2) 2.5 ~I 
2. dNTPmix 200~M (each) 0.5 ~I 
3. Primer STlmixtur 25 pmol 0.25 ~I 
4. Primer ST2 mixture 25 pmol 0.25 ~I 
5. MgCIz 25mM 0.5 ~I 
6. Taq DNA polymerase 0.625 U 0.125 ~I 
7. Distilled water 1O .875~1 
Total volume of Master Mix 15 ~I 
Extracted DNA template 10~1 
Final Volume per reaction 25~1 
Table 2 : Master mixture preparation for first round of PCR 
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2.7.3 Thermal cycle for first round of peR: 
First step 95°C for 5 minutes (initial denaturation) 
Second step 94°C for denaturation-----I min 
Third step 57°C for prime annealing-----I min 
Fourth step n oc for elongation--I min 
Then second step is repeated fourty times 
Fifth step n oc for 7 minutes (final extension step) 
2.7.4 Master mixture preparation for 2nd round PCR 
No Reagent Amount per reaction (cone) Amount per reaction (volume) 
I. peR buffer 
(with MgCh) 2.5 III 
2. dNTPmix 2001lM (each) 0.5 III 
3. Primer STI mixlur 25 pmol 0.25 III 
4. Primer ST2 mixture 25 pmol 0.25 j!I 
5. MgCh 25mM 0.5 III 
6. Taq DNA polymerase 0.625 U 0. 125 111 
7. Distilled water 15.875111 
Total volume of Master Mix 20 III 
Extracted DNA template 5 III 
Final Volume per reaction 25fll 
Table 3 : Master mixture preparation for second round of PCR 
Chapter 2: Materials & Methods 24 
2.7.5 Thermal cycle for 2nd round of peR: 
First step 
Second step 
Third step 
Fourth step 
95°C for 5 minutes (initial denaturation) 
94°C for denaturation-----I min 
57°C for prime annealing----I min 
72°C for e1ongation----1 min 
Then second step is repeated fourty times 
Fifth step 72°C for 7 minutes (final extension step) 
2.7.6 Agarose Gel electropboresis : 
Reagents: Agarose, Tris-Borate-EDT A (TBE) buffer, Ethidium bromide, 100bp ladder. 
Preparation of 1.5% Agarose gel 
I. TBE buffer was taken (100 ml) In a conical flask and added 1.5 gm 
Agarose powder into it. 
2. The flask was heated for 3 minutes in microwave oven. 
3. Ethidium Bromide was added (4 Ill) and mixed properly. 
4. The mixture was layed on gel tray for cooling. 
5. PCR samples were stained with loading dye. (4 III dye with 10111 PCR 
product). 
6. Electrophoresis was performed for 90 minutes at 80V. 
7. The gel was observed under UV light in gel-doc machine. 
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Chapter Three 
Results 
Results 
3.1 Detection of Salmonella enterica serovar Typbi by nested peR using 
different nucleic acid extraction metbods. 
Demographic Data : 
Parameter Number 
Patient enrolled 53 
Blood collected From 53 patients 
Gender Percentage 
Male 27 (51%) 
Female 26 (49%) 
Fifty three (53) patients were enrolled in this study from Dhaka hospital of leDDR, Band 
Kamalapur field site. Among them 27 (51 %) persons were male. Blood was collected from 
all patients studied here. 
3.2 Optimization of DNA extraction procedure: 
For the evaluation of efficient DNA extraction procedure nested pe R was performed using 
DNA samples extracted from spiked blood by using different extraction procedures. 
3.2.1 Nested peR results of DNA samples (on ly even number) extracted by a procedure 
described by Haque et al. [66] showed successful detection of bacteria at 1.9 X 102 cfulml 
of spiked blood (Figure 6). However a nonspecific band was also observed in a negative 
control in similar dilutions with no bacteria ( Lane 8). 
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Fig 6: Electrophoresis of the peR products perfonned by using 1.5% agarose gel. Lanes 1-5 
indicate positive peR bands for 1.9XI0' O, 1.9x 108, 1.9x 106, 1.9xI04 and 1.9xI02 cfu/ml 
respectevly. Lane 8 indicate non specific band in a dilution with no bacteria where, lanes 17 
and 18 indicate positive (st-004) and 19 indicate negative control respectively. 
3.2.2 Nested peR results of DNA samples (only even number) extracted by direct boiling 
procedure showed successful detection of bacteria at 1.6xl02 cfulml of spiked blood 
(Figure 7). However two nonspecific bands were also observed in dilutions with no bacteria 
( Lanes 12 and 18). 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Fig 7: Electrophoresis of the peR products perfonned by using 1.5% agarose gel. Lanes 2-6 
indicate positive peR bands for 1.6XIO IO, 1.6X108, 1.6X106, 1.6xI04 and 1.6xI02 cfulml 
respectevly. Lanes 12 and 18 indicate nonspecific bands in dilutions with no bacteria where, 
lane 19 and 20 indicate positive (st-004) and negative control respectively. 
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3.2.3 Nested peR results of DNA samples extracted by Qiagen kit: It showed successful 
detection of bacteria at 1.5x I 0 cfulml of spiked blood (Figure 8). But here bands have been 
found also in dilutions with individually 1.5 and 0. 15 cfulml of bacteria in lanes 5 and 6. 
Here lanes 9 and 10 indicate negative and positive (st-004) control respectively. 
1 2 3 4 5 6 7 8 9 10 
Fig 8: Electrophoresis of the peR products performed by using 1.5% agarose gel. Lanes 1-4 
indicate positive peR bands for 1.5XIO IO, 1.5X103, 1.5XI02 and 1.5XIOcfulmi respectevly. 
But lanes 5 and 6 indicates positive bands in dilutions with individually 1.5 and 0. 15 cfulml 
of bacteria. Here lanes 9 and 10 indicate negative and positive (st-004) control respectively. 
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3.3 Detection of S. typhi in blood of patients with typhoid fever 
Out of fifty three (53) patients 14 (26.4%) were positive by blood culture . 
3.3.1 DNA extraction from patient's blood specimens by using commercial 
Qiagen Kit. 
Nested PCR was done for S. Typhi detection of four (4) patients of blood culture positive 
samples. Only One (25%) patient was positive in PCR method among 4 blood culture 
confirmed typhoid patients. 
1 2 3 4 5 6 7 
Fig II : Electrophoresis of the PCR products performed by using 1.5% agarose gel. Lanes 1-
4 indicate patient's blood sample where lane I shows only one band. Lane 6 is positive 
control (st·OO4) and lane 7 indicates in negative control. 
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3.3.2 DNA extraction from patient's blood specimens by using a previously 
described procedure: 
Nested PCR was done for typhi detection of all patients regardless of blood culture positive 
and negative using a procedure described earlier (R. Boom et ai, [65]). A total of5 (35.7%) 
patients were positive in PCR method among 14 blood culture confirmed typhoid patients. 
12 (30.8%) patients were also found positive by PCR among blood culture negative patients. 
Parameters Number 
Total Blood Samples 53 
Culture (+) ve 14 
Culture (-) ve 39 
PCR positive of Culture (+) ve 5 
PCR positive of Cu Iture (-) ve 12 
Table 4 : Detection of Typhi by nested PCR method in blood culture (+)ve and (-)ve 
patients. 
1 2 3 4 5 6 7 8 9 10 11 
Fig 10 : Electrophoresis of the PCR products performed by using 1.5% agarose gel. Lanes 1-
7 indicate blood specimen from patients. Lane 9 indicates a positive control (st-004) and, 
lane II is negative control where no sample was inlcluded in lane 8 and 10. 
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Chapter Four 
Discussion 
Discussion 
In this study peR method used by different scientists to diagnose typhoid fever patients 
in Bangladesh was evaluated for devising a better procedure to diagnose the disease at 
low bacterial titer. 
Three different methods were tried for extracting Salmonella Typhi DNA from blood as 
well as laboratory control specimens. To optimize the DNA extraction procedure from 
blood, spiked invitro grown S. Typhi bacteria was added to blood. The blood was serially 
diluted to detennine the minimum concentration of bacteria that could be extracted from 
the blood specimens. 
A method previously described by Haque et at. [66] was sensitive upto 1.9x I 02 cfu/ml in 
blood. So this method is not sensitive enough to use for typhoid fever blood specimens, 
because this is very high load of bacteria that might be necessary to be present in blood 
for detection of S.Typhi. In natural infection, the concentration of S. Typhi is much 
lower. 
Another method that was tried, the direct boiling method which was sensitive up to 
1.6x I 02 cfu/ml in blood. So this method was also not sensitive enough for diagnostic 
purposes for typhoid fever from blood specimens. However, by this method the 
separation on agarose gel gave distinct and sharp bands. The amount of bacteria was 
however very high that might be necessarily being present in blood obtained from a 
patient. 
The third method tried was utilizing the commercial Qiagen kit method. Here sharp bands 
obtained after electrophoresis and bacteria up to 1.5x I 0 cfulml could be detected. Thus 
Chapter 4: Discussion 31 
this was the best procedure and was comparatively more sensitive than the above 
methods. 
The commercial Qiagen kit was found to be the most sensitive method for DNA 
extraction from blood. The other two methods were not able to extract DNA for detect of 
S. Typhi as efficiently and was more sensitive. Based on this comparative study the 
Qiagen kit method was used for DNA extraction from blood of patients suspected of 
typhoid fever. 
The DNA extraction from patient's blood using the Qiagen kit however did not look 
promising because only one patient was positive by peR out of four blood culture 
positive specimens tested. Thus, another method which was described earlier by Boom's 
et al. [65] was used for detection of S. Typhi from blood of suspected typhoid fever 
patient. In this method it was observed that 5 patients were positive for pe R out of 14 
blood culture confirmed patients. DNA extraction was also done in blood culture 
negative samples by this method (Boom's et al. [65]). Here, 12 (31%) positive for pe R 
out of 39 culture negative samples were found. 
There are some drawbacks in DNA extraction procedures especially when specimens 
with low concentration of bacteria are used. In the method described by Haque et al [66] 
one unexpected band was found and same was observed by the direct boiling method. 
This could have been being due to contamination with S. Typhi. 
In thi s exploratory study it was observed that, S. Typhi could be detected from the 
patient's blood specimen by peR method for diagnostic purpose. More study is needed to 
evaluate the efficacy of peR method for detecting S. Typhi at low concentration in blood. 
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Chapter Six 
Appendices 
Appendices 
Appendix 1 
Preparation of Pbospbate buffered Saline (PBS) (PH-7.2) ( I Itr) : 
NaCI 80.00 gm 
Na2HP04 11.50 gm 
KH2P04 2.00gm 
KCI 2.00 gm 
Deionized water 1000.00 ml 
Appendix 2 
Reagent Preparation for DNA extraction (DNA extraction by R. Boom et al. (651) : 
Diatom Suspension 
I. Deionized water (10 mL) was taken into a 50 mL Falcon tube. 
2. Diatomaceous Earth (5 g) was added into it. 
3. The tube was filled upto 50ml with deionized water (dH20). 
4. The tube was shaken vigorously (to making MUD). 
5. The diatoms allowed to settle down for 3 hours (30 minutes minimum). 
6. The upper Liquid layer was removed. 
7. The tube was refilled upto 50 mL with dH20 and mixed properly. 
8. Then the tube was allowed to settle down for 2 hours (30 minutes minimum). 
9. The upper liquid layer was removed. 
10. A volume of dH20 equal to the semi-solid MUD was added. 
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II. The diatom suspension after vortexed aliquoted into small volumes (0.5-1.0 
ml) and autoclaved (I SIbs for 15 minutes). Then stored at room temperature. 
Buffers 
Preparation ofSOmM lOOml Tris-HCI (PH 6.4): 
I. Tris (0.606g) in a conical flask was taken and deionized water (90mJ) was 
added into the flask. 
2. The mixture was stired and the pH was adjusted to 6.4 by adding HCI. 
3. The final volume was made 100mJ by adding dH20 . 
Preparation of L2 extraction buffer (SOml): 
I. GuSCN (32g) in a conical flask was taken and Tris-HCI was added uplo 
50ml. 
2. The flask was heated at 65°C for 10-20 minutes to dissolve GuSCN. 
3. The solution was filtered through 1.2~m filter and transferred to a 50 ml 
falcon tube. Then stored at RT. 
4. The conical flask was covered by aluminium foil and falcon tube was 
covered by brown paper. 
Preparation of L6 extraction buffer (SOml): 
5. GuSCN (32g) in a conical flask was taken and Tris-HCI was added uplo 
50mJ. 
6. The flask was heated at 65°C for 10-20 minutes to dissolve GuSCN. 
7. EDTA (0.292g) and Triton X-loo (I00~1) were added. The mixture was 
stired for 10 min for mixing. 
8. The solution was filtered through 1 .2~m filter and transferred to a 50 ml 
falcon tube. Then stored at RT. 
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9. The conical flask was covered by aluminium foil and falcon tube was 
covered by brown paper. 
Appendix 3 
Reagents for DNA extraction using commercial Qiagen Kit : 
The Reagents were provided by the Qiagen reagent company. 
Appendix 4 
Buffer preparation for DNA Extraction (DNA extraction by Haque et al. 166]) : 
For SO mJ buffer 
I. Tris Hel (10 ml of 50 mM) was taken in a bottle. 
2. Deionized water (40 ml) was added into it. 
3. The PH adjusted to 8. 
4. EDTA (0.0146 g) was added into it and stired to dissolve. 
5. Then triton X (200 111) was added and mixed properly. 
Appendix 5 
Preparation of Tris-EDT A (TE) buffer (l00ml) 
I. Deionized water (105 ml) with 0.2 11m was filtered and 95 mI was taken in a 
beaker. 
2. Tris (0.1211 g) was added into it. 
3. The solution was stired and the pH was adjusted at 8. 
4. EDTA (0.0292g) was added there and stired to dissolve. 
5. The filtered deionized water was added upto 100ml. 
6. The solution was filtered with 0.2 11m filter and autoclaved. 
7. Then stored at +4°C. 
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Appendix 6 
Preparation ofTBE buffer (lOx): 
Tris 
Boric Acid 
Na-EDTA 
The deionized water was autoclaved upto 1 L 
Appendix 7 
Loading dye composition (6X) 
0.25% BPB (Bromo Phenol Blue): 0.025 g 
0.05% XC (Xylene Cyanol FF) : 0.5 ml 
100 mM EDTA : 2 ml 
: 5 mI 
12.1g 
6.0 
0.74g 
(Stock 1 % BPB 
(Stock I%XC 
(Stock 0.5 mM 
2.5 mI) 
0.5 ml) 
2.0 rnl) 
(Stock 100% Gly 5.0 m!) 50% Glycerol 
Distilled water : Rest of water Nil 
For 10 rnl IOmI 
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